Working together for Health for all, Hunger for none

In today’s world, we value the things we took for granted. But for many, our most basic needs are still out of reach. So, how do we make things better?

Explore Your Topic

Tuesday, November 3, 2020

News Conference Call Q3

Breast Cancer – Risk Factors and Diagnosis Methods

Family Planning

100 Million Women by 2030 – Choice for Every One of Them

Our Products

Can We Live Better?

Can 10 billion of us live better?

5 Myths About Breast Cancer

A Virtual Event Series for Everyone, Everywhere

Uses and Safety Record

Let’s Talk About Glyphosate

Links

Information for Patients

Modern Slavery Act Statement.pdf (PDF 2.05 MB)

Latest News

Share Price / Index

October 30, 2020 10:04 CEST

October 30, 2020 10:04 CEST

October 26, 2020

Not intended for U.S. and UK Media

Rivaroxaban application submitted to U.S. FDA for new indication in patients after lower-extremity revascularization due to symptomatic PAD

October 26, 2020

Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy

October 23, 2020

Not intended for U.S. and UK Media – Data from Phase III FIDELIO-DKD study presented at the American Society of Nephrology (ASN)’s Kidney Week 2020

Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Medical Advisor für den Kardiorenalen-Bereich (m/w/d)

Germany Leverkusen

Integrated Evidence Generation (IEG) Data Analyst (m/f/d)

Betriebsingenieur im pharmazeutischen Produktionsbetrieb flüssiger Arzneimittel (m/w/d)

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Consumer Health